Is averaging down a good idea with CSV? I still can't believe that the market is pricing the stock at around 60c. It is very oversold IMHO, but would like to hear from other holders.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%
